Physician profile
Syed A Fehmi
NPI 1942320288
$17,287.08
in general payments reported to CMS, 2019-2025
13 companies · $3,252 in 2025
The $3,252 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,093 · 2020: $5,195 · 2021: $167 · 2022: $37.23 · 2023: $350 · 2024: $193 · 2025: $3,252.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,950 · Food and Beverage: $845.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,950.00 |
| Food and Beverage | $844.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $8,694.75 | 2019-2025 | Resolution 360 Ultra Clip |
| Olympus Medical Systems Corporation | $2,950.00 | 2025 | Evis Exera III Duodenovideoscope |
| Wilson Cook Medical Incorporated | $2,500.00 | 2019 | |
| Olympus Corporation of The Americas | $2,237.17 | 2019 | |
| Fujifilm Healthcare Americas Corporation | $298.39 | 2023-2025 | Fujifilm |
| Madrigal Pharmaceuticals | $135.77 | 2024 | Resmetirom |
| Cook Medical LLC | $105.84 | 2019-2025 | Hemospray |
| Micro-Tech Endoscopy USA, INC. | $95.86 | 2023-2024 | Eyemax |
| Conmed Corporation | $85.31 | 2021 | |
| Olympus America INC. | $63.50 | 2023-2025 | Visiglide, Single Use Electrosurgical Knife Kd-655 |
| Medtronic, INC. | $56.33 | 2021-2022 | |
| Steris Corporation | $34.09 | 2021-2025 | |
| Apollo Endosurgery US INC | $30.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Fehmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.